Literature DB >> 22094341

The decline and resurgence of pertussis in the US.

Pejman Rohani1, John M Drake.   

Abstract

Although the resurgence of pertussis in nations with long-standing vaccination programs has raised serious concerns about the effectiveness of current immunization policy, the epidemiology of resurgence remains poorly understood. We analyzed pertussis notifications in US states obtained from the National Notifiable Disease Surveillance System from 1951 to 2010 to explore the timing, spatial pattern and consistency of resurgence across the country. Here we show that resurgence occurred at different times in different states, spread out over a transition period of roughly three decades. Further, despite this spatial variation, broad patterns in pertussis epidemiology can be described by two dominant phases: (1) a period of decline ending in the mid-1970s, followed by (2) nationwide resurgence. Together, these patterns explain 89.7% of the variation in US case notifications between 1951 and 2005. This resurgence was interrupted, however, by a synchronized downturn in 2005 that continues to the present in many large states. The causes of these two transitions in pertussis epidemiology remain hotly debated, though our findings suggest that evolution of the Bordetella pertussis bacterium, loss of immunity and persistent transmission among adults, and demographic drivers are more probable explanations than changes in reporting or the introduction of acellular vaccines.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 22094341     DOI: 10.1016/j.epidem.2011.10.001

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  49 in total

Review 1.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

2.  Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand.

Authors:  Julie C Blackwood; Derek A T Cummings; Hélène Broutin; Sopon Iamsirithaworn; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

3.  Pertussis and the Minnesota State Fair: Demonstrating a Novel Setting for Efficiently Conducting Seroepidemiologic Studies.

Authors:  Erinn Sanstead; Nicole E Basta; Karen Martin; Victor Cruz; Kristen Ehresmann; Shalini Kulasingam
Journal:  J Community Health       Date:  2018-10

4.  Dynamics of Pertussis Transmission in the United States.

Authors:  F M G Magpantay; P Rohani
Journal:  Am J Epidemiol       Date:  2015-05-27       Impact factor: 4.897

5.  Combating pertussis resurgence: One booster vaccination schedule does not fit all.

Authors:  Maria A Riolo; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 6.  [Recent progress in clinical research on pertussis].

Authors:  Dan-Xia Wu; Qiang Chen; Kun-Ling Shen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

7.  Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.

Authors:  J C Blackwood; D A T Cummings; S Iamsirithaworn; P Rohani
Journal:  Epidemics       Date:  2016-03-19       Impact factor: 4.396

8.  Vaccine providers' perspectives on impact, challenges, and response during the California 2010 pertussis outbreak.

Authors:  Jessica L Silvaggio; Joshua Van Otterloo; Eileen A Curran; Ellen A S Whitney; Paul S Weiss; Katherine Seib; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2013-09-18       Impact factor: 3.452

Review 9.  Prevention of pertussis through adult vaccination.

Authors:  Manika Suryadevara; Joseph B Domachowske
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 10.  Resolving pertussis immunity and vaccine effectiveness using incidence time series.

Authors:  Jennie S Lavine; Pejman Rohani
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.